Meriwether Wealth & Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$973K Buy
12,444
+2,617
+27% +$211K 0.48% 40
2026
Q1
$852K Buy
9,827
+239
+2% +$22.9K 0.47% 43
2025
Q4
$921K Buy
9,588
+117
+1% +$11.4K 0.52% 38
2025
Q3
$902K Sell
9,471
-144
-1% -$13.2K 0.52% 37
2025
Q2
$838K Sell
9,615
-723
-7% -$61.3K 0.53% 38
2025
Q1
$929K Buy
10,338
+1,357
+15% +$121K 0.61% 37
2024
Q4
$717K Buy
+8,981
New +$777K 0.51% 44

Other funds holding MDT

Meriwether Wealth & Planning's MDT Position: Q2 2026 in Review

Meriwether Wealth & Planning increased its Medtronic (MDT) stake by 27% in Q2 2026, buying an estimated $211K and bringing the position to 12,444 shares worth $973K. The position accounts for 0.48% of the portfolio, ranked #40.

Meriwether Wealth & Planning first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Meriwether Wealth & Planning held 12,444 shares of Medtronic worth $973K as of Q2 2026.
  • Meriwether Wealth & Planning bought 2,617 Medtronic shares in Q2 2026, an estimated $211K.
  • Medtronic made up 0.48% of Meriwether Wealth & Planning's portfolio in Q2 2026, its #40 holding.
  • Meriwether Wealth & Planning first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q2 2026, filed 8 Jul 2026.